Matches in Wikidata for { <http://www.wikidata.org/entity/Q92274074> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q92274074 description "clinical trial" @default.
- Q92274074 description "ensayo clínico" @default.
- Q92274074 description "ensayu clínicu" @default.
- Q92274074 description "klinisch onderzoek" @default.
- Q92274074 description "клінічне випробування" @default.
- Q92274074 name "Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study." @default.
- Q92274074 name "Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study." @default.
- Q92274074 type Item @default.
- Q92274074 label "Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study." @default.
- Q92274074 label "Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study." @default.
- Q92274074 prefLabel "Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study." @default.
- Q92274074 prefLabel "Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study." @default.
- Q92274074 P1050 Q92274074-50F8C610-3647-46D5-862E-AB239C8A2765 @default.
- Q92274074 P1132 Q92274074-4928FFB4-7333-49F0-A141-32BAAB82557D @default.
- Q92274074 P1476 Q92274074-7D55A93E-C385-451A-8AA7-8F9B50F08A53 @default.
- Q92274074 P17 Q92274074-A5D60D89-1661-4D64-B9CF-AD5BE9DC1A16 @default.
- Q92274074 P2899 Q92274074-B1A997D9-47E4-4DEF-87C8-34B29577D037 @default.
- Q92274074 P3098 Q92274074-145C9F26-87EB-4806-BF66-D49638F1819F @default.
- Q92274074 P31 Q92274074-09AC33C6-DE6A-4118-A8DE-6B0E6ADD9BDF @default.
- Q92274074 P4135 Q92274074-6B4F1757-6B42-451D-9648-658952C49BFA @default.
- Q92274074 P4844 Q92274074-0E341ACC-AF28-4526-A2D1-57A0EE81B401 @default.
- Q92274074 P4844 Q92274074-1CB3B115-5C5D-4E87-A4AB-A919B320F764 @default.
- Q92274074 P580 Q92274074-A8A0ABA7-8C9B-4D67-9788-D5AA908F401E @default.
- Q92274074 P582 Q92274074-FD6B84E0-E4C0-4601-AD32-1BBCB4484BB5 @default.
- Q92274074 P8363 Q92274074-A7893A2E-AF48-4F2F-8C9A-FF3CF6AC61C7 @default.
- Q92274074 P921 Q92274074-44FB5DC4-8637-451A-A53E-28FB136AA823 @default.
- Q92274074 P1050 Q12192 @default.
- Q92274074 P1132 "+55" @default.
- Q92274074 P1476 "Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study." @default.
- Q92274074 P17 Q28 @default.
- Q92274074 P2899 "+16" @default.
- Q92274074 P3098 "NCT04352855" @default.
- Q92274074 P31 Q30612 @default.
- Q92274074 P4135 "+90" @default.
- Q92274074 P4844 Q21011231 @default.
- Q92274074 P4844 Q423376 @default.
- Q92274074 P580 "2018-01-18T00:00:00Z" @default.
- Q92274074 P582 "2020-05-19T00:00:00Z" @default.
- Q92274074 P8363 Q818574 @default.
- Q92274074 P921 Q31856 @default.